BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28435982)

  • 1. [Changes in biological functions of high-density lipoprotein after abnormal modification].
    Qu H; Yu Y; Qin SC; Song GH
    Sheng Li Xue Bao; 2017 Apr; 69(2):225-234. PubMed ID: 28435982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease.
    Moradi H; Pahl MV; Elahimehr R; Vaziri ND
    Transl Res; 2009 Feb; 153(2):77-85. PubMed ID: 19138652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures.
    Van Lenten BJ; Hama SY; de Beer FC; Stafforini DM; McIntyre TM; Prescott SM; La Du BN; Fogelman AM; Navab M
    J Clin Invest; 1995 Dec; 96(6):2758-67. PubMed ID: 8675645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of poloxamer 407 on the functional properties of HDL in mice.
    Yasuda T; Johnston TP; Shinohara M; Inoue M; Ishida T
    J Pharm Pharmacol; 2012 May; 64(5):677-87. PubMed ID: 22471363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidative activity of HDL particle subspecies is impaired in hyperalphalipoproteinemia: relevance of enzymatic and physicochemical properties.
    Kontush A; de Faria EC; Chantepie S; Chapman MJ
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):526-33. PubMed ID: 14739123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intravenous apolipoprotein A-I/phosphatidylcholine discs on paraoxonase and platelet-activating factor acetylhydrolase in human plasma and tissue fluid.
    Kujiraoka T; Hattori H; Ito M; Nanjee MN; Ishihara M; Nagano M; Iwasaki T; Cooke CJ; Olszewski WL; Stepanova IP; Egashira T; Miller NE
    Atherosclerosis; 2004 Sep; 176(1):57-62. PubMed ID: 15306175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of overexpression of human apo A-I in C57BL/6 and C57BL/6 apo E-deficient mice on 2 lipoprotein-associated enzymes, platelet-activating factor acetylhydrolase and paraoxonase. Comparison of adenovirus-mediated human apo A-I gene transfer and human apo A-I transgenesis.
    De Geest B; Stengel D; Landeloos M; Lox M; Le Gat L; Collen D; Holvoet P; Ninio E
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):E68-75. PubMed ID: 11031226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation.
    Moore RE; Navab M; Millar JS; Zimetti F; Hama S; Rothblat GH; Rader DJ
    Circ Res; 2005 Oct; 97(8):763-71. PubMed ID: 16151025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid substitution therapy induces high-density lipoprotein-associated platelet-activating factor-acetylhydrolase in patients with subclinical hypothyroidism: a potential antiatherogenic effect.
    Milionis HJ; Tambaki AP; Kanioglou CN; Elisaf MS; Tselepis AD; Tsatsoulis A
    Thyroid; 2005 May; 15(5):455-60. PubMed ID: 15929667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein profile, lipoprotein-associated phospholipase A2 and cardiovascular risk in hemodialysis patients.
    Rolla R; De Mauri A; Valsesia A; Vidali M; Chiarinotti D; Bellomo G
    J Nephrol; 2015 Dec; 28(6):749-55. PubMed ID: 25971848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E-containing HDL-associated platelet-activating factor acetylhydrolase activities and malondialdehyde concentrations in patients with PCOS.
    Fan P; Liu H; Wang Y; Zhang F; Bai H
    Reprod Biomed Online; 2012 Feb; 24(2):197-205. PubMed ID: 22197603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein-associated PAF-acetylhydrolase activity in subjects with the metabolic syndrome.
    Rizos E; Tambaki AP; Gazi I; Tselepis AD; Elisaf M
    Prostaglandins Leukot Essent Fatty Acids; 2005 Mar; 72(3):203-9. PubMed ID: 15664305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antioxidant properties of high-density lipoproteins in atherosclerosis.
    Mackness B; Mackness M
    Panminerva Med; 2012 Jun; 54(2):83-90. PubMed ID: 22525563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.
    Watson AD; Berliner JA; Hama SY; La Du BN; Faull KF; Fogelman AM; Navab M
    J Clin Invest; 1995 Dec; 96(6):2882-91. PubMed ID: 8675659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The function, composition, and particle size of high-density lipoprotein were severely impaired in an oliguric phase of hemorrhagic fever with renal syndrome patients.
    Cho KH; Park SH; Park JE; Kim YO; Choi I; Kim JJ; Kim JR
    Clin Biochem; 2008 Jan; 41(1-2):56-64. PubMed ID: 17996200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The functional and compositional properties of lipoproteins are altered in patients with metabolic syndrome with increased cholesteryl ester transfer protein activity.
    Park KH; Shin DG; Kim JR; Hong JH; Cho KH
    Int J Mol Med; 2010 Jan; 25(1):129-36. PubMed ID: 19956911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory investigation of dysfunctional HDL.
    Guo ZG; Li C; Zhong JK; Tu Y; Xie D
    Chem Phys Lipids; 2012 Jan; 165(1):32-7. PubMed ID: 22064068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Amyloid A, Paraoxonase-1 Activity, and Apolipoprotein Concentrations as Biomarkers of Subclinical Atherosclerosis Risk in Adrenal Incidentaloma Patients.
    Imga NN; Topcuoglu C; Berker D; Turhan T
    Arch Med Res; 2018 Apr; 49(3):182-190. PubMed ID: 30031631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles.
    Marathe GK; Zimmerman GA; McIntyre TM
    J Biol Chem; 2003 Feb; 278(6):3937-47. PubMed ID: 12466264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.